Protecting recognition sequences on DNA by a cleavage-deficient restriction endonuclease

Biotechniques. 1993 Aug;15(2):310-5.

Abstract

This report describes the use of a biochemical tool that has been developed to aid in the manipulation of DNA. A DNA binding-proficient and cleavage-deficient BamHI mutant protein, E113K, was used in vitro to protect its recognition sequence (5'-GGATCC-3') against the catalytic action of site-specific endonuclease, exonuclease and methylase. In vitro conditions are reported here in which the E113K protein protects BamHI sites (5'-GGATCC-3') from cleavage by BamHI endonuclease or Sau3AI endonuclease (5'-GATC-3'); protects a neighboring restriction site 5'-CCCGGG-3' from SmaI endonuclease digestion; blocks methylation of 5'-GGATCC-3' by Dam methylase (5'-GATC-3'); and blocks Bal31 exonuclease progression at a BamHI site. The Bal31 procedure could be used to generate unidirectional deletions of a DNA fragment. The use of mutant endonucleases that are binding-proficient and cleavage-deficient to shield DNA from nuclease digestion or methylase modification expands the repertoire of methods to manipulate DNA in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • DNA / chemistry*
  • DNA Restriction Enzymes / metabolism*
  • Deoxyribonuclease BamHI / genetics
  • Deoxyribonuclease BamHI / metabolism*
  • Deoxyribonucleases, Type II Site-Specific / metabolism
  • Endodeoxyribonucleases / metabolism
  • Methyltransferases / metabolism
  • Molecular Sequence Data
  • Mutation
  • Site-Specific DNA-Methyltransferase (Adenine-Specific)*

Substances

  • DNA
  • Methyltransferases
  • Dam methyltransferase
  • Site-Specific DNA-Methyltransferase (Adenine-Specific)
  • Endodeoxyribonucleases
  • exonuclease Bal 31
  • DNA Restriction Enzymes
  • Deoxyribonuclease BamHI
  • CCCGGG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific
  • GATC-specific type II deoxyribonucleases